Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cardona

Showing results (311-320 of 333) with videos related to

Pageof 34
Sort By:
Journal of Neuro-Oncology|September 9, 2021
Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutationAndrés F Cardona, Daniel Jaramillo-Velásquez, Alejandro Ruiz-Patiño, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2026
Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18‒55 Years OldPatricia Winokur, Oyeniyi Diya, David Fitz-Patrick, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP)Andrés F Cardona, Leonardo Rojas, Zyanya Lucia Zatarain-Barrón, et al.
Thoracic Cancer|March 17, 2021
Characteristics and outcomes of thymomas in Latin America: Results from over 10 years of experience (CLICaP-LATimus)Claudio Martín, Diego Enrico, Luis Mas, et al.
Thoracic Cancer|December 13, 2019
Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non-small cell lung cancer (NSCLC) compared with chemotherapy (Quijote-CLICaP)Alejandro Ruiz-Patiño, Oscar Arrieta, Andrés F Cardona, et al.
The New England Journal of Medicine|January 18, 2023
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 YearsPatricia Winokur, Juleen Gayed, David Fitz-Patrick, et al.
Lancet Regional Health. Americas|December 30, 2022
Classification of Alzheimer's disease and frontotemporal dementia using routine clinical and cognitive measures across multicentric underrepresented samples: A cross sectional observational studyMarcelo Adrián Maito, Hernando Santamaría-García, Sebastián Moguilner, et al.
Biomedica : Revista Del Instituto Nacional De Salud|December 13, 2022
Prognostic significance of telomerase reverse transcriptase promoter gen mutations in high grade meningiomasAlejandro Cañas, Enrique Jiménez, Fernando Hakim, et al.
ESMO Open|June 26, 2022
Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitorsL Rojas, D Mayorga, A Ruiz-Patiño, et al.
Oncology|November 27, 2018
Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin AmericaOscar Arrieta, Andrés F Cardona, Guillermo Bramuglia, et al.
Pageof 34

Showing results (311-320 of 333) with videos related to

Sort By:
Pageof 34
Journal of Neuro-Oncology|September 9, 2021
Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutationAndrés F Cardona, Daniel Jaramillo-Velásquez, Alejandro Ruiz-Patiño, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2026
Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18‒55 Years OldPatricia Winokur, Oyeniyi Diya, David Fitz-Patrick, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP)Andrés F Cardona, Leonardo Rojas, Zyanya Lucia Zatarain-Barrón, et al.
Thoracic Cancer|March 17, 2021
Characteristics and outcomes of thymomas in Latin America: Results from over 10 years of experience (CLICaP-LATimus)Claudio Martín, Diego Enrico, Luis Mas, et al.
Thoracic Cancer|December 13, 2019
Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non-small cell lung cancer (NSCLC) compared with chemotherapy (Quijote-CLICaP)Alejandro Ruiz-Patiño, Oscar Arrieta, Andrés F Cardona, et al.
The New England Journal of Medicine|January 18, 2023
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 YearsPatricia Winokur, Juleen Gayed, David Fitz-Patrick, et al.
Lancet Regional Health. Americas|December 30, 2022
Classification of Alzheimer's disease and frontotemporal dementia using routine clinical and cognitive measures across multicentric underrepresented samples: A cross sectional observational studyMarcelo Adrián Maito, Hernando Santamaría-García, Sebastián Moguilner, et al.
Biomedica : Revista Del Instituto Nacional De Salud|December 13, 2022
Prognostic significance of telomerase reverse transcriptase promoter gen mutations in high grade meningiomasAlejandro Cañas, Enrique Jiménez, Fernando Hakim, et al.
ESMO Open|June 26, 2022
Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitorsL Rojas, D Mayorga, A Ruiz-Patiño, et al.
Oncology|November 27, 2018
Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin AmericaOscar Arrieta, Andrés F Cardona, Guillermo Bramuglia, et al.
Pageof 34